# AMPH — Amphastar Pharmaceuticals Inc · catalysts, narrative & risks

**Deep-research report — K3vl4r**  
**Symbols:** AMPH  
**Sources:** 27  
**Published:** 2026-10-04  
**Canonical:** https://app.k3vl4r.com/research/deep-research-amph-amphastar-pharmaceuticals-inc-catalysts-narrative-r-6031

---

# Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) — as of 2026-10-04

## Recent Catalysts (last ~1–3 months)

**FDA warning letter to a California facility.** One of Amphastar's subsidiaries received a warning letter from the U.S. FDA regarding manufacturing-related violations at a California facility, and the stock traded lower in premarket trading in connection with the disclosure [[1]](https://seekingalpha.com/news/4612201-amphastar-stock-slips-fda-warning-letter).

---

_Preview only. The complete multi-source deep-research report — full thesis, evidence, and citations — is available at https://app.k3vl4r.com/research/deep-research-amph-amphastar-pharmaceuticals-inc-catalysts-narrative-r-6031 (free to sign up)._
